NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanovery

Nanovery

Private
Newcastle upon TyneHealthcare & Life Scienceshttps://nanovery.co.uk/

Last Round

Accelerator

Jun 10, 2025

Total Funding Raised

$5.43M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nanovery is a biotechnology company that develops a proprietary Nucleic Acid Nanorobotics (NANs) platform for precise RNA therapeutic analysis, biomarker quantification, and early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

nucleic acid nanoroboticsNANsRNA therapeuticsbioanalysispharmacokinetic bioanalysisbiomarker detectionenzyme-free detectionantisense oligonucleotidesASOsmall interfering RNAsiRNADNA nanotechnologyassay developmentlab-on-a-chipmolecular diagnosticsbiotech reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanovery Comps

Public and private peers based on sector, stage, and business model.

Nanovery comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 10, 2025
SeedApr 10, 2025
GrantApr 1, 2025
GrantApr 12, 2023
SeedApr 12, 2023
Grant
Sep 1, 2022

Key People

Founding team and executive leadership

Roma Galloway

Co-Founder, COO

Founding Team

Jerzy Kozyra

Founder, Chief Executive Officer

Founding Team

Nanovery Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 551% MoM, reaching 2.1K.

  • Apr 20, 2026

    Monthly visitors grew 135% MoM, reaching 1K.

Nanovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewcastle upon Tyne
Employee Range16
Year Founded2018
Last FundingJun 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.